Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB4 known ✓ | P30926 | 1/20 | 0.35 |
| ▸ | CHRNA3 known ✓ | P32297 | 1/20 | 0.35 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | AOC3 | Q16853 | 4/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.35 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | MTOR | P42345 | 1/20 | 0.35 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.34 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5664548 | 0.98 | HCAR2 (0.43) | HCAR2LMNAALDH1A1KDM4EKMT2A | |
| Fluoride SCHEMBL28527584 | 0.97 | HCAR2 (0.42) | HCAR2LMNAALDH1A1KDM4EKMT2A | |
| Iodide SCHEMBL22042239 | 0.97 | HCAR2 (0.42) | HCAR2LMNAALDH1A1KDM4EKMT2A | |
| Bromide SCHEMBL28534138 | 0.97 | HCAR2 (0.42) | HCAR2LMNAALDH1A1KDM4EKMT2A | |
| Ethyl Chloride SCHEMBL5032981 | 0.92 | HCAR2 (0.38) | HCAR2LMNAALDH1A1KDM4EHSD17B10 | |
| Hydrochloric Acid SCHEMBL21693858 | 0.86 | HCAR2 (0.41) | HCAR2LMNAALDH1A1KDM4EKMT2A | |
| Bromide SCHEMBL21693860 | 0.83 | HCAR2 (0.41) | HCAR2LMNAALDH1A1KDM4EKMT2A | |
| Iodide SCHEMBL21693887 | 0.83 | HCAR2 (0.41) | HCAR2LMNAALDH1A1KDM4EKMT2A | |
| Fluoride SCHEMBL28507999 | 0.83 | HCAR2 (0.41) | HCAR2LMNAALDH1A1KDM4EKMT2A | |
| Hydrochloric Acid SCHEMBL28537615 | 0.83 | LMNA (0.38) | HCAR2LMNAALDH1A1KDM4EKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115322386-A | Amphoteric polyacrylamide, and preparation method and application thereof | 浙江传化华洋化工有限公司 | 2022-11-11 | — | — | CN | claimed |
| CN-110407974-B | Preparation method of crosslinkable amphoteric polyacrylamide polymer | 浙江传化华洋化工有限公司 | 2021-09-21 | — | — | CN | claimed |
| CN-103509180-B | Polymeric dispersions and the method preparing polymeric dispersions | AKZO NOBEL N. V. (NL) | 2015-12-09 | — | — | CN | claimed |
| US-20040024242-A1 | Method for making aqueous solutions of (meth)acryloyloxyethylbenzyldimethylammonium chlorides | ATOFINA (FR) | 2004-02-05 | — | — | US | claimed |
| EP-4508160-A1 | COMPOSITIONS COMPRISING POLYMER, SCALE INHIBITOR AND QUATERNARY AMMONIUM COMPOUND, METHOD AND USES | Independence Oilfield Chemicals, LLC (US) | 2025-02-19 | — | — | EP | disclosed |
| CN-113631682-B | Polymer dispersions for wax inhibition during stimulation | 能源解决方案(美国)有限责任公司 | 2024-01-26 | — | — | CN | disclosed |
| WO-2023210593-A1 | METHOD FOR TREATING ORGANIC WASTEWATER CONTAINING AMIDE COMPOUNDS | KJ CHEMICALS CORPORATION (JP) | 2023-11-02 | — | — | WO | disclosed |
| WO-2023199013-A1 | COMPOSITIONS COMPRISING POLYMER, SCALE INHIBITOR AND QUATERNARY AMMONIUM COMPOUND, METHOD AND USES. | INDEPENDENCE OILFIELD CHEMICALS LLC (US) | 2023-10-19 | — | — | WO | disclosed |
| US-20230322977-A1 | AQUEOUS FORMULATIONS | INDEPENDENCE OILFIELD CHEMICALS LLC | 2023-10-12 | — | — | US | disclosed |
| CN-113166050-B | Method for producing organotellurium compound and method for producing vinyl polymer | 大塚化学株式会社 | 2023-04-18 | — | — | CN | disclosed |
| CN-110709052-B | Hair composition in foam form providing improved moisturized feel in application | 宝洁公司 | 2023-04-04 | — | — | CN | disclosed |
| CN-110709057-B | Hair care compositions providing improved in-use moisturized feel | 宝洁公司 | 2023-04-04 | — | — | CN | disclosed |
| EP-1511776-A1 | A WATER-SOLUBLE POLYMER DISPERSION AND A METHOD OF PRODUCING A WATER-SOLUBLE POLYMER DISPERSION | AKZO Nobel N.V. (NL) | 2005-03-09 | — | — | EP | disclosed |
| US-20050034829-A1 | Sheet surface treating and ink-jet printing paper | HYMO CORPORATION | 2005-02-17 | — | — | US | disclosed |
| US-20040024242-A1 | Method for making aqueous solutions of (meth)acryloyloxyethylbenzyldimethylammonium chlorides | ATOFINA (FR) | 2004-02-05 | — | — | US | disclosed |
| US-6669815-B1 | Cationic graft copolymer comprising vinyl alcohol and di(meth)allylamine-based or N-vinylcarboxylic acid amide comonomers | HYMO CORPORATION (JP) | 2003-12-30 | — | — | US | disclosed |
| WO-2003097703-A1 | A WATER-SOLUBLE POLYMER DISPERSION AND A METHOD OF PRODUCING A WATER-SOLUBLE POLYMER DISPERSION | AKZO NOBEL N.V. (NL) | 2003-11-27 | — | — | WO | disclosed |
| EP-1022383-B1 | SHEET SURFACE TREATING AGENT AND INK-JET PRINTING PAPER | HYMO CORP (JP) | 2003-11-26 | — | — | EP | disclosed |
| EP-1022383-A1 | SHEET SURFACE TREATING AGENT AND INK-JET PRINTING PAPER | HYMO CORPORATION (JP) | 2000-07-26 | — | — | EP | disclosed |
| US-5260480-A | Quaternization process | NORSOLOR (FR) | 1993-11-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040024242-A1 | Method for making aqueous solutions of (meth)acryloyloxyethylbenzyldimethylammonium chlorides | DDT, BCHE, ACMSD | CHRNB4 1849/4885CHRNA3 726/4885HCAR2 3886/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.